
En desarrollo
Salud·2/6/2026Resumen IA
Cancer: New immunotherapies and targeted therapies show promise
The Chicago Cancer Congress unveiled promising advances in lung cancer treatment, including a new immunotherapy, ivonescimab, showing superiority over current treatments. Targeted therapy for "RET" anomalies also demonstrated significant success in preventing relapse.
F
France Info2 min de lectura
